Latest news
Stargardt pill could slow progression of disease
Posted: Wednesday 10 May 2023 at 00:00
A new drug to treat Stargardt disease has helped to slow down the progression of the condition in some patients, according to the latest results of a phase two clinical trial.
Find out more
Biosimilars - the cheaper drugs for macular degeneration
Posted: Wednesday 3 May 2023 at 00:00
As patents for existing drugs to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) expire we hear from professor Richard Gale, on what this means for patients and ophthalmology services.
Find out more
"You have to remind yourself what you can achieve"
Posted: Wednesday 3 May 2023 at 00:00
Judy, 79 has taken on the remarkable challenge of climbing the O2 in London in her determination to show others what they can achieve.
Find out more
Warhammer fundraiser to raise awareness of macular disease
Posted: Friday 14 April 2023 at 00:00
A twelve-year-old Warhammer fanatic is organising a fundraising tournament in memory of his beloved late grandad, to raise awareness of macular disease and support others with the condition, after seeing the impact it had on his life.
Find out more
‘Inspirational’ Ann, 99, sets out to complete marathon walking challenge
Posted: Wednesday 5 April 2023 at 00:00
An inspirational 99-year-old is celebrating her milestone year by walking the equivalent distance of a marathon around her local running track in a bid to help beat macular disease.
Find out more
Treatment delays – “It’s vitally important to speak out”
Posted: Wednesday 5 April 2023 at 00:00
Stories of delays to vital treatment for age-related macular degeneration (AMD) have been hitting the headlines over the last few weeks. While the news is concerning for many people affected, Pam, who was diagnosed with wet AMD in 2021, has shared why she has spoken out about her own experiences to the national press and why she would encourage others to do the same.
Find out more
New drug for dry AMD - your questions answered
Posted: Tuesday 4 April 2023 at 00:00
In February we shared the exciting news that the first-ever drug to treat dry age-related macular degeneration (AMD) has been approved in the US. With the support of Apellis Pharmaceuticals, which has brought the drug to market, we answer some of your most frequently asked questions.
Find out more
Do you suffer from pain after your eye injection?
Posted: Monday 3 April 2023 at 00:00
While many people don’t experience any problems from their regular eye injections, there are a few others who have complained about pain or discomfort in the hours following the treatment.
Find out more
Changes to voting affecting blind and partially sighted people
Posted: Monday 3 April 2023 at 00:00
The local elections next month will be the first time people across the country will be asked to provide photo ID in order to vote.
Find out more
Workforce Census illustrates severe shortage of eye doctors
Posted: Friday 31 March 2023 at 00:00
The Macular Society has reacted with concern to The Royal College of Ophthalmologist’s 2022 Workforce Census, which reveals the shortage of eye doctors in the UK and the extent of pressure on NHS ophthalmology services.
Find out more
“I wanted to do something to challenge myself”
Posted: Friday 31 March 2023 at 00:00
A grandmother of four with age-related macular degeneration (AMD) will be taking on her first-ever marathon this month, at the age of 70.
Find out more
"People don’t consider that there will be a life after diagnosis"
Posted: Wednesday 1 March 2023 at 00:00
Beverley has been a Macular Society counsellor for more than 20 years. In this time she has spoken to hundreds of people struggling to come to terms with the life-changing diagnosis of macular disease.
Find out more